Abstract:Background Numerous neuropsychiatric symptoms, including affective symptoms, chronic fatigue syndrome, and fibromyalgia symptoms, are present in patients with end-stage renal disease (ESRD). This study examines the relationship between neuropsychiatric symptoms and red blood cell (RBC) parameters, kidney function tests, zinc, C-reactive protein, and calcium levels in patients with ESRD.Methods The above biomarkers and the Beck-Depression Inventory, the Hamilton Anxiety Rating Scale, and the Fibro-Fatigue Rating Scale were measured in 70 patients with end-stage renal disease (ESRD) and 46 healthy controls.Results Increased scores of depressive, anxious, cognitive, and physiosomatic symptoms (including chronic fatigue, fibromyalgia, and autonomous symptoms) characterise ESRD. One latent vector could be extracted from these diverse symptom domains, which are, therefore, manifestations of a common core referred to as the physio-affective phenome. The combined effects of aberrations in red blood cells (RBC) (number of RBC, hematocrit, and haemoglobin), kidney function tests (glomerular filtration rate, ureum, creatinine, albumin, and total serum protein), C-reactive protein, zinc, and copper explained 85.0% of the variance in the physio-affective phenome. In addition, the effects of kidney function decline on the phenome were partially mediated by RBC aberrations and elevated copper, whereas the effects of dialysis frequency were entirely mediated by decreased zinc and elevated CRP.Conclusions Affective (depression and anxiety), cognitive, and physiosomatic symptoms due to ESRD are interrelated manifestations of the physio-affective phenome, which is driven by (in descending order of importance) kidney dysfunctions, erythron deficits, inflammation, elevated copper, and decreased zinc.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis study did not receive any funding ### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional ethics board of the University of Kufa (Document No.2229T /2022) and the Najaf Health Directorate, Training, and Human Development Center (Document No.20123 / 2022) approved the present study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript

Serum Agrin and Talin Are Increased in Major Depression While Agrin and Creatine Phosphokinase Are Associated with Chronic Fatigue and Fibromyalgia Symptoms in Depression.

The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with peripheral inflammation, insulin resistance and lowered calcium

In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation.

In major dysmood disorder, physiosomatic, chronic fatigue and fibromyalgia symptoms are driven by immune activation and increased immune-associated neurotoxicity

Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.

"Functional" or "psychosomatic" Symptoms, E.G. A Flu-Like Malaise, Aches and Pain and Fatigue, Are Major Features of Major and in Particular of Melancholic Depression

Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression.

Neuromediator and hormonal perturbations in fibromyalgia syndrome: results of chronic stress?

Total Serum-Protein and Serum-Protein Fractions in Depression - Relationships to Depressive Symptoms and Glucocorticoid Activity

IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression

Evidence for Inflammation and Activation of Cell-Mediated Immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Increased Interleukin-1, Tumor Necrosis Factor-Α, PMN-elastase, Lysozyme and Neopterin.

Lower DTI-ALPS index in patients with major depressive disorder: correlation with fatigue

Increased Serum IgM Antibodies Directed Against Phosphatidyl Inositol (pi) in Chronic Fatigue Syndrome (CFS) and Major Depression: Evidence That an IgM-mediated Immune Response Against Pi is One Factor Underpinning the Comorbidity Between Both CFS and Depression.

Depression, Anxiety, and Chronic Fatigue Symptoms in Acute Rheumatoid Arthritis Are Associated with Immune-Inflammatory, Autoimmune, Endogenous Opioid System and Lactosylceramide Signaling Pathways: a Nomothetic Network Approach.

Serum Interleukin Levels and Insulin Resistance in Major Depressive Disorder

Increased expression of ER stress, inflammasome activation, and mitochondrial biogenesis-related genes in peripheral blood mononuclear cells in major depressive disorder

In End-Stage Kidney Disease, Inflammation, Erythron Abnormalities and Declined Kidney Function Tests Are Accompanied by Increased Affective Symptoms, Chronic-Fatigue, and Fibromyalgia

Correlations Among Mrna Expression Levels Of Atp7a, Serum Ceruloplasmin Levels, And Neuronal Metabolism In Unmedicated Major Depressive Disorder

Alterations in Iron Metabolism and the Erythron in Major Depression: Further Evidence for a Chronic Inflammatory Process.

An IgM-mediated Immune Response Directed Against Nitro-Bovine Serum Albumin (Nitro-Bsa) in Chronic Fatigue Syndrome (CFS) and Major Depression: Evidence That Nitrosative Stress is Another Factor Underpinning the Comorbidity Between Major Depression and CFS.

Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder.